{"altmetric_id":19809559,"selected_quotes":["New global #mesothelioma #immunotherapy trial now recruiting patients who aren't eligible for surgery"],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Bristol-Myers Squibb"],"first_seen_on":"2017-05-03T11:42:10+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1505455763,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02899299","https:\/\/clinicaltrials.gov\/show\/NCT02899299","https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02899299"],"nct_id":"NCT02899299","pubdate":"2016-08-31T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients (CheckMate743)","type":"clinical_trial_study_record"},"altmetric_score":{"score":3.95,"score_history":{"1y":3.95,"6m":3.95,"3m":0.25,"1m":0.25,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3.95},"context_for_score":{"all":{"total_number_of_other_articles":8418826,"mean":7.0849522326371,"rank":1919994,"this_scored_higher_than_pct":77,"this_scored_higher_than":6489104,"rank_type":"exact","sample_size":8418826,"percentile":77},"similar_age_3m":{"total_number_of_other_articles":248047,"mean":12.692231908597,"rank":73025,"this_scored_higher_than_pct":70,"this_scored_higher_than":174419,"rank_type":"exact","sample_size":248047,"percentile":70},"this_journal":{"total_number_of_other_articles":24831,"mean":10.521629963753,"rank":7318,"this_scored_higher_than_pct":70,"this_scored_higher_than":17489,"rank_type":"exact","sample_size":24831,"percentile":70},"similar_age_this_journal_3m":{"total_number_of_other_articles":726,"mean":10.93715862069,"rank":102,"this_scored_higher_than_pct":85,"this_scored_higher_than":624,"rank_type":"exact","sample_size":726,"percentile":85}}},"demographics":{"poster_types":{"member_of_the_public":4,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":4,"Practitioners (doctors, other healthcare professionals)":1}}},"geo":{"twitter":{"US":2,"GB":2}}},"counts":{"total":{"posts_count":6},"twitter":{"unique_users_count":5,"unique_users":["PHD4Meso","grandmamavis","SWMesoSupport","PacificMesoCtr","asbestosfirst"],"posts_count":5},"facebook":{"unique_users_count":1,"unique_users":["1460722300883694"],"posts_count":1}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/PHD4Meso\/statuses\/866911552376520704","license":"gnip","citation_ids":[19809559],"posted_on":"2017-05-23T06:59:55+00:00","author":{"name":"Raymond Wong, Ph.D.","url":"http:\/\/www.phlbi.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2473487869\/c58pe4efu20gd66a7u16_normal.jpeg","description":"Immunologist now researching immunotherapeutic strategies for malignant pleural mesothelioma and other thoracic cancers.","id_on_source":"PHD4Meso","tweeter_id":"733547707","geo":{"lt":34.05223,"ln":-118.24368,"country":"US"},"followers":70},"tweet_id":"866911552376520704"},{"url":"http:\/\/twitter.com\/grandmamavis\/statuses\/866912304243367936","license":"gnip","rt":["PHD4Meso"],"citation_ids":[19809559],"posted_on":"2017-05-23T07:02:54+00:00","author":{"name":"Mavis Nye BCAh","url":"http:\/\/www.onestopmesothelioma.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/899594923095330816\/cTkiulC2_normal.jpg","description":"Mesowarriors UK FB Mesothelioma UK Advocate Patient Rep EKent NHS Research St Barts Leic Saatchi Bill- Asbestos Activist \nhttp:\/\/rayandmave.wordpress.com\/","id_on_source":"grandmamavis","tweeter_id":"16923689","geo":{"lt":null,"ln":null},"followers":2964},"tweet_id":"866912304243367936"},{"url":"http:\/\/twitter.com\/SWMesoSupport\/statuses\/866912370089754625","license":"gnip","rt":["PHD4Meso"],"citation_ids":[19809559],"posted_on":"2017-05-23T07:03:10+00:00","author":{"name":"SWMSG","image":"https:\/\/pbs.twimg.com\/profile_images\/751846568215646213\/XLIFuzq7_normal.jpg","description":"'Support & Awareness of Asbestos Related Cancer & Diseases' - Devon & Cornwall.  Hold regular support group meetings in Plymouth & Truro.","id_on_source":"SWMesoSupport","tweeter_id":"2805448045","geo":{"lt":50.37153,"ln":-4.14305,"country":"GB"},"followers":592},"tweet_id":"866912370089754625"},{"url":"http:\/\/twitter.com\/PacificMesoCtr\/statuses\/867144910289256449","license":"gnip","rt":["PHD4Meso"],"citation_ids":[19809559],"posted_on":"2017-05-23T22:27:12+00:00","author":{"name":"Pacific Meso Center","url":"http:\/\/www.phlbi.org\/pacific-mesothelioma-center\/","image":"https:\/\/pbs.twimg.com\/profile_images\/557971615485419520\/smZYx89i_normal.jpeg","description":"The PMC mission is to better serve a growing number of mesothelioma victims by supporting the first-of-its-kind and only in-house research lab in the nation.","id_on_source":"PacificMesoCtr","tweeter_id":"733641594","geo":{"lt":34.05223,"ln":-118.24368,"country":"US"},"followers":139},"tweet_id":"867144910289256449"},{"url":"http:\/\/twitter.com\/asbestosfirst\/statuses\/869667173148631044","license":"gnip","rt":["PHD4Meso"],"citation_ids":[19809559],"posted_on":"2017-05-30T21:29:46+00:00","author":{"name":"Debbie Hales","url":"http:\/\/www.asbestosfirst.co.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/522691117662216192\/NjqxKDC5_normal.jpeg","description":"Enthusiastic, happy, contented but driven to excellence. Love working in partnership helping with asbestos issues, hate hearing about scaremongering!","id_on_source":"asbestosfirst","tweeter_id":"20270411","geo":{"lt":51.38764,"ln":0.50546,"country":"GB"},"followers":98},"tweet_id":"869667173148631044"}],"facebook":[{"title":"Nivolumab with, without ipilimumab benefits patients with malignant pleural mesothelioma","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1978391689116750&id=1460722300883694","license":"public","citation_ids":[19809559],"posted_on":"2017-09-15T06:09:23+00:00","summary":"15\/09\/17-Europe\nThe MAP2 #mesothelioma immunotheraphy Opdivo + Yeroy trial has reported encouraging results at the European Society for Medical Oncology 2017 Congress at Madrid. \n\nComment: A different, and relative new trial involving both these drugs vers","author":{"name":"Mesothelioma and Asbestos Related Support Australia","url":"https:\/\/www.facebook.com\/1460722300883694","facebook_wall_name":"Mesothelioma and Asbestos Related Support Network Australia","image":"https:\/\/graph.facebook.com\/1460722300883694\/picture","id_on_source":"1460722300883694"}}]}}